(Q44195299)
Statements
Irbesartan reduces the albumin excretion rate in microalbuminuric type 2 diabetic patients independently of hypertension: a randomized double-blind placebo-controlled crossover study (English)
Ornella Carbonara
Dario Iafusco
Teresa Salvatore
Rosanna D'Ambrosio
Roberto Torella
Domenico Cozzolino
1 November 2002